Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Why do patients with cancer die?
2024 Standout
Global Epidemiology and Genetics of Hepatocellular Carcinoma
2023 Standout
Works of P. Foa being referenced
Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.
2011
Dose intensity correlate with survival in elderly patients treated with chemotherapy for advanced non-small cell lung cancer
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| P. Foa | 136 | 240 | 180 | 148 | 26 | 501 | |
| T. Girinsky | 90 | 248 | 182 | 99 | 22 | 569 | |
| Romeo A. Mandanas | 102 | 92 | 166 | 225 | 21 | 456 | |
| Camilla Molich Hoff | 95 | 164 | 137 | 141 | 20 | 571 | |
| Loredana Costa | 200 | 172 | 63 | 123 | 29 | 489 | |
| In Keun Choi | 82 | 131 | 95 | 82 | 36 | 417 | |
| Richard Lizambri | 310 | 177 | 159 | 49 | 16 | 506 | |
| Umut Dişel | 78 | 145 | 107 | 47 | 46 | 459 | |
| Jan‐Erik Johansson | 118 | 117 | 170 | 32 | 29 | 443 | |
| Francesco Grimaldi | 69 | 120 | 161 | 66 | 29 | 449 | |
| J M Cosset | 88 | 217 | 313 | 54 | 32 | 540 |
All Works
Loading papers...